FRI0390 DUKE-3: A 15-week open-label trial of pegloticase in refractory gout including patients with solid organ transplant or prior pegloticase treatment
Publication
, Conference
Sundy, JS; Gansen, N; Kelly, S; Scarlett, E; Jaggers, D; Hershfield, MS
Published in: Annals of the Rheumatic Diseases
June 2013
Duke Scholars
Published In
Annals of the Rheumatic Diseases
DOI
EISSN
1468-2060
ISSN
0003-4967
Publication Date
June 2013
Volume
71
Issue
Suppl 3
Start / End Page
446.2 / 446
Publisher
Elsevier BV
Related Subject Headings
- Arthritis & Rheumatology
- 3204 Immunology
- 3202 Clinical sciences
- 1117 Public Health and Health Services
- 1107 Immunology
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Sundy, J. S., Gansen, N., Kelly, S., Scarlett, E., Jaggers, D., & Hershfield, M. S. (2013). FRI0390 DUKE-3: A 15-week open-label trial of pegloticase in refractory gout including patients with solid organ transplant or prior pegloticase treatment. In Annals of the Rheumatic Diseases (Vol. 71, pp. 446.2-446). Elsevier BV. https://doi.org/10.1136/annrheumdis-2012-eular.2847
Sundy, J. S., N. Gansen, S. Kelly, E. Scarlett, D. Jaggers, and M. S. Hershfield. “FRI0390 DUKE-3: A 15-week open-label trial of pegloticase in refractory gout including patients with solid organ transplant or prior pegloticase treatment.” In Annals of the Rheumatic Diseases, 71:446.2-446. Elsevier BV, 2013. https://doi.org/10.1136/annrheumdis-2012-eular.2847.
Sundy JS, Gansen N, Kelly S, Scarlett E, Jaggers D, Hershfield MS. FRI0390 DUKE-3: A 15-week open-label trial of pegloticase in refractory gout including patients with solid organ transplant or prior pegloticase treatment. In: Annals of the Rheumatic Diseases. Elsevier BV; 2013. p. 446.2-446.
Sundy, J. S., et al. “FRI0390 DUKE-3: A 15-week open-label trial of pegloticase in refractory gout including patients with solid organ transplant or prior pegloticase treatment.” Annals of the Rheumatic Diseases, vol. 71, no. Suppl 3, Elsevier BV, 2013, pp. 446.2-446. Crossref, doi:10.1136/annrheumdis-2012-eular.2847.
Sundy JS, Gansen N, Kelly S, Scarlett E, Jaggers D, Hershfield MS. FRI0390 DUKE-3: A 15-week open-label trial of pegloticase in refractory gout including patients with solid organ transplant or prior pegloticase treatment. Annals of the Rheumatic Diseases. Elsevier BV; 2013. p. 446.2-446.
Published In
Annals of the Rheumatic Diseases
DOI
EISSN
1468-2060
ISSN
0003-4967
Publication Date
June 2013
Volume
71
Issue
Suppl 3
Start / End Page
446.2 / 446
Publisher
Elsevier BV
Related Subject Headings
- Arthritis & Rheumatology
- 3204 Immunology
- 3202 Clinical sciences
- 1117 Public Health and Health Services
- 1107 Immunology
- 1103 Clinical Sciences